Romosozumab was not effective in preventing multiple spontaneous clinical vertebral fractures after denosumab discontinuation: A case report

Discontinuation of denosumab is associated with the increase of bone turnover markers to above-baseline levels (so-called rebound in bone turnover) and rapid bone loss. Several studies have reported vertebral fractures (VFs), particularly multiple spontaneous clinical VFs (MSCVFs), occurring after d...

Full beskrivning

Sparad:
Bibliografiska uppgifter
I publikationen:Bone Rep
Huvudupphovsmän: Kashii, Masafumi, Ebina, Kosuke, Kitaguchi, Kazuma, Yoshikawa, Hideki
Materialtyp: Artigo
Språk:Inglês
Publicerad: Elsevier 2020
Ämnen:
Article
Länkar:https://ncbi.nlm.nih.gov/pmc/articles/PMC7284126/
https://ncbi.nlm.nih.gov/pubmed/32548215
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.bonr.2020.100288
Taggar: Lägg till en tagg
Inga taggar, Lägg till första taggen!

Liknande verk